Summary
Overview
Work History
Education
Skills
Affiliations
Board Of Directors
Languages
Timeline
Generic

Carmella Angus

Winnipeg,MB

Summary

Ms. Angus’s career spans over 30 years in all facets of the Health Care Industries including the development, manufacturing and commercialization of pharmaceuticals, over the counter medicines as well as medical and dental devices. Ms. Angus is an expert in operational and P&L management, strategic planning, business development, product development, product launch and mergers/acquisitions. Ms. Angus’s experiences have included both global public companies such as AstraZeneca, Pfizer/Warner Lambert and Pharmacia and non-profit hospital organizations such as UHN and St. Michaels. Ms. Angus is also the founder of two companies within the dental and /medical devices business as well as defence technologies.

Overview

28
28
years of professional experience

Work History

Clinical Research Manager

Astra Zeneca
  • Designed and implemented studies in Psychiatry and Neurology
  • Analyzed the research data and managed the clinical studies in psychiatry and neurology
  • Managed all phases of product development.

Cardiology Research Manager

St. Michaels Hospital
  • Contributed to breakthrough concepts that contributed to major advances in cardiovascular care.

Manager of an Intensive Care Unit

University Health Network
  • Contributed to setting Intensive Care standards across Canada and USA
  • Contributed to the role nurses can play as primary diagnosticians.

CEO and Founder

Nova Dentech Inc and AC Nova Technologies Inc
01.2011 - 01.2023
  • Acquired a Medical/Dental devices company in business for 40 years
  • Licensed from the University of Singapore a Platform Technology for Over The Counter products in women and men’s health, bone health and heart health
  • Prepared annual 1) business plans 2) budgets and 3) marketing strategies
  • Through organic growth, marketing and turnaround strategies increased profits by 30% with EBITDA of 20%
  • Trained staff in “state of the art” manufacturing processes and material science
  • Converted hands on manufacturing process into digital processes such as CAD-CAM/3D Print etc
  • Acquired 4 other companies and merged them with Nova Dentech Inc
  • Prepared submissions and was approved for 3 Health Canada approvals
  • Identified 4 investors willing to invest
  • Selected two equity partners and provided a 40% ROI for the investors upon exit
  • Obtained research grants and rebates for 9 consecutive years
  • Managed all aspects of P&L, operations, manufacturing and 25 direct reports.

Regional President for Canada and USA Interim CEO

Dentamach International Inc
01.2008 - 01.2011
  • Was an .5 Million Equity Investor in Dentamach International Inc
  • Increased Revenues from 200K to 4 million within 9 months and managed operations
  • Appointed Interim CEO for Head Office in Peapack New Jersey
  • Prepared the content and the design of Corporate Brochures for marketing and potential Investors
  • Prepared company valuations for 6 potential acquisitions
  • Prepared annual business and financial plans and prepared acquisition strategies.

CEO for USA and Canada

Tetrad Technologies Inc
01.2006 - 01.2008
  • Advisor to the founder of Tetrad (a top Physicist in defence technologies at the Proof of Concept stage)
  • Identified a technology suitable for the prevention of the spread of viruses, bacteria and fungi
  • Presented our technologies to Bombardier, Department of Homeland Security and CDC for prevention of microbial spread
  • Prepared a technology proposal that landed Tetrad in the International Nanotechnology competition in Veneto Italy of which only 15 countries participated
  • Scientific Advisor to the Board composed of Chairman of the post Taliban monitoring group for the United Nations
  • Technology readiness advisor to the Commercialization Officer for the Department of Homeland Security
  • Participated in a Border Security Symposia in Ottawa Canada
  • Collaborated with a Scientist at Oakridge National Lab and Physicists in Quebec to prepare an international collaborative defence project.

Commercialization and Medical Affairs Consultant

Pharmacia
01.2001 - 01.2006
  • Launched 2 products in Infectious Diseases and Ophthalmology
  • Launched a 300K a year product and turned it into 1 M a year blockbuster
  • Designed commercialization marketing plans and clinical studies for infectious diseases and ophthalmology products
  • Submitted studies to Health Canada which were approved.

Medical Affairs Director

Warner Lambert and Pfizer
01.1995 - 01.2000
  • Prepared the marketing and launch strategy for Lipitor which became a multibillion dollar product due to our strategies
  • Designed and conducted an 18,000 patient study to assess cardiovascular risk factors
  • Planned and managed a 20 million dollar clinical research budget
  • Collaborated with Pfizer during the product launch and during the acquisition of Warner Lambert
  • Managed the medical affairs staff
  • Submitted proposals for cardiovascular and endocrinology products to Health Canada that were approved.

Education

BScN - Nursing

Faculty of Nursing University of Toronto

MSc - Neuroscience and Cardiovascular

Faculty of Medicine University of Toronto

MBA - Global Business Management

University of Phoenix
Arizona USA
06.2006

Skills

  • Extensive Research experience
  • Budget Planning and P&L management
  • Innovative and Visionary
  • Brand and Marketing management
  • Talent Development
  • Strategic business planning
  • Partnership and Negotiation
  • Extensive Acquistion experience
  • Product Development and Product Launch experience
  • Excellent written and oral communications
  • Problem solver and works well under pressure
  • Account Management
  • Good Clinical Practices

Affiliations

  • Ontario College of Nurses
  • Order of the Eastern Star, Current Officer and Past Worthy Matron of one of the largest benevolent organization dedicated to raising funds for various charitable causes such as diabetes, heart disease, autism, cancer etc.
  • Delta Kappa Gamma, Honorary Member of DKG an International Educators Organization

Board Of Directors

  • Board Director, Nova DenTech Inc, 01/01/2011, 12/31/2020
  • Board Director, Prime Mentors of Canada, 01/01/2013, 12/31/2018, The prime objective is to identify and mentor disadvantaged children “at risk” and to raise funds for education. Once they enter our mentorship program a scholarship is placed in trust to encourage post-secondary education in children with intellectual potential but from disadvantaged socioeconomic backgrounds.
  • Board Director, Condo Corporation MTCC 759, 01/01/2001, 12/31/2007
  • Chairman of the Board of Directors, Condo Corporations TSCC #1839, 01/01/2008

Languages

English
Full Professional
French
Professional Working

Timeline

CEO and Founder

Nova Dentech Inc and AC Nova Technologies Inc
01.2011 - 01.2023

Regional President for Canada and USA Interim CEO

Dentamach International Inc
01.2008 - 01.2011

CEO for USA and Canada

Tetrad Technologies Inc
01.2006 - 01.2008

Commercialization and Medical Affairs Consultant

Pharmacia
01.2001 - 01.2006

Medical Affairs Director

Warner Lambert and Pfizer
01.1995 - 01.2000

Clinical Research Manager

Astra Zeneca

Cardiology Research Manager

St. Michaels Hospital

Manager of an Intensive Care Unit

University Health Network

BScN - Nursing

Faculty of Nursing University of Toronto

MSc - Neuroscience and Cardiovascular

Faculty of Medicine University of Toronto

MBA - Global Business Management

University of Phoenix
Carmella Angus